Atrial fibrillation treated with left atrial appendage closure was associated with ischemic strokes that were less severe than those among similar patients treated with direct oral anticoagulation.
A drug-eluting resorbable scaffold was superior to angioplasty in treating infrapopliteal artery disease and chronic limb-threating ischemia and was noninferior for safety in the LIFE-BTK trial.
The Trilogy transcatheter aortic valve replacement system was safe and effective for high-risk surgical patients with aortic regurgitation, improving LV remodeling and function, in the ALIGN-AR trial.
The two types of imaging catheter, as guides for coronary stent targeting and deployment, led to similar clinical outcomes in the OCTIVUS trial. A meta-analysis backed it up.